| DC Field | Value | Language |
|---|
| dc.contributor.author | Gulevskaya, O. N. | - |
| dc.contributor.author | Galenko-Yaroshevsky, P. A. | - |
| dc.contributor.author | Lebedeva, S. A. | - |
| dc.contributor.author | Sukoyan, G. V. | - |
| dc.contributor.author | Pavlyuchenko, I. I. | - |
| dc.date.accessioned | 2022-05-06T11:55:33Z | - |
| dc.date.available | 2022-05-06T11:55:33Z | - |
| dc.date.issued | 2021 | - |
| dc.identifier.citation | Mafusol and its combination with REXOD as correctors of reduced blood circulation in the skin associated with normoglycemia or diabetes mellitus complicated by exogenous hypercholesterolemia / O.N. Gulevskaya [et al.] // Research Results in Pharmacology. - 2021. - Vol.7, №2.-P. 1-14. - Doi: 10.3897/rrpharmacology.7.54319. | ru |
| dc.identifier.uri | http://dspace.bsu.edu.ru/handle/123456789/46637 | - |
| dc.description.abstract | The search for and development of new highly active medications and their combinations of the appropriate direction of action remains an urgent problem due to the complications of diabetes mellitus, especially burdened with atherosclerosis, including skin and vascular lesions | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | pharmacology | ru |
| dc.subject | mafusol | ru |
| dc.subject | rexod | ru |
| dc.subject | alprostadil | ru |
| dc.subject | skin | ru |
| dc.subject | reduced blood circulation | ru |
| dc.subject | alloxan diabetes | ru |
| dc.subject | exogenous hypercholesterolemia | ru |
| dc.title | Mafusol and its combination with REXOD as correctors of reduced blood circulation in the skin associated with normoglycemia or diabetes mellitus complicated by exogenous hypercholesterolemia | ru |
| dc.type | Article | ru |
| Appears in Collections: | Vol. 7, № 2
|
